Multiple treatment interruptions and protecting HIV-specific CD4 T cells enable durable CD8 T cell response and viral control.
Jain A, Canepa GE, Liou ML, Fledderman EL, Chapoval AI, Xiao L, Mukherjee I, Balogun BM, Huaman-Vergara H, Galvin JA, Kumar PN, Bordon J, Conant MA, Boyle JS.
Jain A, et al. Among authors: xiao l.
Front Med (Lausanne). 2024 May 14;11:1342476. doi: 10.3389/fmed.2024.1342476. eCollection 2024.
Front Med (Lausanne). 2024.
PMID: 38808136
Free PMC article.